Cardiometabolic Health Congress (CMHC)
Avatar

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

By Cardiometabolic Health Congress (CMHC) FEATURING Lance Sloan
By Cardiometabolic Health Congress (CMHC) FEATURING Lance Sloan
0 views
June 17, 2019
Comments 3
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Recommended

AUTOPLAY
06:38
Allan Jaffe

What Does Elevated Troponin Mean in COVID-19?

64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
61:49
Obafemi Awolowo University

Management of Heart Failure

Feat. O. A. Akinyele
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

08:46
Robert Busch

FLOW Trial Results: GLPs, the Kidneys, and Even More to Come!!

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

26:49
Diana Isaacs

Tirzepatide Updates

20:24
Diana Isaacs

Tirzepatide for Type 2 Diabetes

19:23
PKD Foundation

Genetic Testing in PKD: The Benefits and the Challenges

Feat. L. Noureddine
21:19
Patricia Kao

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

06:31
Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

38:09
Houston Methodist Hospital

Multimodal Integrative Approach to Kidney Disease: Dietary Managemen…

Feat. K. Kalantar-Zadeh
05:08
Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

36:34
Scripps Health

GLP-1 Hysteria

Feat. S. Harris